ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

BFRIW Biofrontera Inc

0.06
0.00 (0.00%)
May 06 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 0.03
Ask Price 0.0659
News -
Share Name Share Symbol Market Stock Type
Biofrontera Inc BFRIW NASDAQ Equity Warrant
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 0.06 15:02:00
Open Price Low Price High Price Close Price Previous Close
0.06 0.06
Trades Shares Traded Average Volume
0 0 -
Last Trade Type Quantity Price Currency
- 0  0.06 USD

Biofrontera Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.33M 1.37M - 34.07M -20.13M -14.72 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News Biofrontera

Real-Time news about Biofrontera Inc (NASDAQ): 0 recent articles
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No BFRIW Message Board. Create One! See More Posts on BFRIW Message Board See More Message Board Posts

BFRIW Historical

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.000.000.000.0000.000.00%
5 Years0.000.000.000.0000.000.00%

Biofrontera Inc is a biopharmaceutical company specializing in the commercialization of pharmaceutical products for the treatment of dermatological conditions, diseases caused by exposure to sunlight that result in sun damage to the skin. Its licensed products focus on the treatment of actinic keratoses, which are skin lesions that can sometimes lead to skin cancer. It also markets a topical antibiotic for the treatment of impetigo, a bacterial skin infection.

Your Recent History

Delayed Upgrade Clock